Pharmaceutical Care Overview
13 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What does the 'R' in the IRP model stand for?

  • Regulation of drug dosages
  • Reassessment of patient compliance
  • Review of drug interactions
  • Resolving drug and patient related problems (correct)
  • Which of the following is not a function of therapeutic care?

  • Improvement of patient cooperation (correct)
  • Prevention of drug related problems
  • Identification of drug related problems
  • Resolution of patient health issues
  • Which outcome is primarily associated with pharmaceutical care?

  • Elimination of the need for hospitalization
  • Improvement of patient adherence to medication
  • Complete recovery from chronic conditions
  • Prevention of disease and its complications (correct)
  • What is a primary reason for drug-related morbidity (DRH)?

    <p>Untreated indications</p> Signup and view all the answers

    Which factor is not considered in individualizing a dosage regimen?

    <p>Health care provider's salary</p> Signup and view all the answers

    How does accumulation of a drug in the body affect a patient?

    <p>May lead to neurotoxic or ototoxic effects</p> Signup and view all the answers

    What is the main difference between Type A and Type B adverse drug reactions?

    <p>Type A reactions are dose-dependent, whereas Type B reactions are dose-independent.</p> Signup and view all the answers

    Which of the following steps is not part of the pharmaceutical care process?

    <p>Conducting surgery</p> Signup and view all the answers

    Which type of adverse drug reaction occurs as a result of withdrawing a medication?

    <p>Type E</p> Signup and view all the answers

    What characterizes a severe adverse drug reaction?

    <p>Intensive care is needed.</p> Signup and view all the answers

    What does sub-therapeutic dose refer to?

    <p>A dose that fails to achieve the desired effect</p> Signup and view all the answers

    Which format includes 'Monitoring' as a component?

    <p>PHARME</p> Signup and view all the answers

    What is the classification used for evaluating adverse drug reactions based on the onset of action?

    <p>Acute, Subactive, Latent</p> Signup and view all the answers

    Study Notes

    Pharmaceutical Care

    • Optimizes drug therapy for better patient outcomes and quality of life.
    • Focuses on rational drug use, ensuring proper drug use for treatment.
    • IRP is a key concept:
      • I: Identification of both drug and patient-related problems.
      • R: Resolving both patient and drug-related problems.
      • P: Prevention of both patient and drug-related problems.

    Outcomes of Pharmaceutical Care

    • Cure: Eliminating the disease.
    • Elimination: Reducing the disease impact.
    • Slow down disease: Inhibiting disease progression.
    • Prevention: Avoiding the development of the disease.

    Pharmaceutical Care Plan

    • An individualised written plan for drug therapy based on specific therapeutic goals.

    Pharmacotherapy

    • Utilizes drugs for disease treatment, prevention, and diagnosis (without radiation or surgery).
    • Relies on one or more drugs.

    Steps in Pharmaceutical Care

    • Patient-Doctor Relationship: Establishing a strong connection for effective care.
    • Data Collection: Gathering information about the patient, their condition, and medications.
    • Data Interpretation: Analyzing the collected data to identify potential problems.
    • Identification of Drug-Related Problems: Recognizing issues related to drug therapy.
    • Prioritizing Drug-Related Problems: Determining the urgency of identified issues.
    • Developing a Therapeutic Plan: Creating a strategy for addressing the problems.
    • Implementing a Monitoring Plan: Establishing a system for tracking progress and potential side effects.
    • Follow-up: Regularly assessing the plan's effectiveness and making adjustments as needed.
    • Therapeutic malfunction resulting in new effects or toxicities.
    • Major contributing factors:
      • Untreated Indications: Inadequate treatment of underlying conditions.
      • Overdose: Exceeding the recommended drug dosage.
      • Subtherapeutic Dose: Insufficient dosage for achieving desired therapeutic effect.

    Adverse Drug Reactions (ADRs)

    • Unwanted outcomes of drug therapy.
    • Classification:
      • Onset of action: Based on the time it takes for ADRs to appear.
      • Active, Subactive, Latent: Categories based on the time between drug exposure and symptom onset.
      • Severity: Classifying ADRs based on their intensity: Minor, Moderate, Severe, Lethal.
    • Types of Reactions:
      • ABCDEF: Based on suspected drug interaction.
      • Hypersensitivity Reactions: Allergic responses to drugs.
      • Allergic Shocks: Severe, life-threatening allergic reactions.
      • Toxic Effects: Adverse reactions caused by high drug concentrations.
    • Acute, Subactive, Latent:
      • Acute: ADRs occurring within 60 minutes.
      • Subactive: ADRs appearing between 1-2 hours.
      • Latent: ADRs developing after 72 days.
    • Severity:
      • Minor: ADRs requiring no specific treatment.
      • Moderate: ADRs requiring therapy modifications.
      • Severe: ADRs needing intensive care.
      • Lethal: ADRs directly or indirectly causing death.
    • Types of ADR:
      • Type A: Augmental, dose-dependent ADRs.
      • Type B: Bizzore, dose-independent ADRs.
      • Type C: Chronic ADRs occurring due to drug metabolism.
      • Type D: Delayed ADRs appearing years after exposure.
      • Type E: End-of-therapy ADRs related to drug withdrawal.
      • Type F: Failure-of-therapy ADRs often resulting from drug interactions.

    Individualization of Dosage Regimen

    • Tailoring drug therapy for optimal outcomes based on patient and drug factors.
    • Patient-Related Factors:
      • Diagnosis
      • Therapeutic Goals
      • Contraindications
      • Allergy
      • Patient Compliance
      • Patient Medical History
      • Patient Cooperation
    • Drug-Related Factors:
      • Efficacy
      • Adverse Effects
      • Drug Administration
      • Pharmacokinetic and Pharmacodynamic Properties
      • Dosage Forms
      • Ability to Monitor
      • Route of Administration

    Reasons for Non-Compliance

    • Factors Contributing to Non-Compliance:
      • Healthcare provider behavior
      • Inappropriate prescriptions
      • Dispensing errors
      • Patient idiosyncrasies

    Pharmacist Workup Drug Therapy (PWDT)

    • Comprehensive assessment of drug therapy by a pharmacist.

    Systemic Documentation

    • Provides guidelines for pharmacist documentation.

    Formats

    • PHARME: A mnemonic for documenting pharmaceutical care.
      • P: Pharmacotherapy problem list
      • H: History
      • A: Assessment
      • R: Recommendation
      • M: Monitoring
      • E: Evaluation
    • PRIME: Another mnemonic for documenting pharmaceutical care.
      • P: Pharmacotherapy Problem
      • R: Risk Factors
      • I: Interactions between drugs, food, and the patient
      • M: Mismatch
      • E: Efficacy
    • SOAP: A common method for documenting patient care.
      • S: Subjective
      • O: Objective
      • A: Assessment
      • P: Plan
    • CORE: An alternative method for documenting pharmaceutical care.
      • C: Condition or Factor
      • O: Outcomes
      • R: Regimen
      • E: Evaluation

    Chapter 2: Adverse Drug Reactions (ADRs)

    • Definition: Unwanted outcomes of drug therapy.
    • Classification:
      • Onset of action: Based on the time it takes for ADRs to appear.
      • Active, Subactive, Latent: Categories based on the time between drug exposure and symptom onset.
      • Severity: Classifying ADRs based on their intensity: Minor, Moderate, Severe, Lethal.
    • Types of Reactions:
      • Type A: Augmental, dose-dependent ADRs.
      • Type B: Bizzore, dose-independent ADRs.
      • Type C: Chronic ADRs occurring due to drug metabolism.
      • Type D: Delayed ADRs appearing years after exposure.
      • Type E: End-of-therapy ADRs related to drug withdrawal.
      • Type F: Failure-of-therapy ADRs often resulting from drug interactions.
    • Pharmaceutical ADRs: Related to changes in dosage form, leading to toxicity or therapeutic index issues.
    • Drug Index Diseases: Diseases caused by drug exposure.
      • Drug Withdrawal: ADRs occurring due to rapid cessation of drug use.
      • Drug Elimination: Adverse reactions due to insufficient drug elimination from the body.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Pharmaceutical Care PDF

    Description

    This quiz explores the fundamental concepts of pharmaceutical care, focusing on optimizing drug therapy to enhance patient outcomes. It covers the key elements of the Integrated Resource Process (IRP), various outcomes of pharmaceutical care, and the development of a pharmaceutical care plan. Test your knowledge on rational drug use and the steps necessary for effective pharmacotherapy.

    More Like This

    Pharmaceutical Services in Healthcare
    10 questions
    Pharmacology Chapter 1 Overview
    12 questions
    Pharmaceutical Care Overview
    8 questions
    Pharmacy Overview and Pharmaceutical Care
    40 questions
    Use Quizgecko on...
    Browser
    Browser